[1]
M. Štuhec, “Epidemiology, pharmacoepidemiology, comparative efficacy and acceptability of drugs in treatment of attention deficit hyperactivity disorder in children and adolescents”, analipazu, vol. 6, no. 1-2, pp. 37–43, Jun. 2022, doi: 10.18690/analipazu.6.1-2.37-43.2016.